The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Britain's FTSE forges ahead as Shire surges

Fri, 16th Oct 2015 15:55

* FTSE 100 ends up 0.6 pct at 6,378.04 points

* Shire lifted by talk it may bid for a U.S. rival

* Burberry extends previous day's slide

* GKN hit by estimates downgrade from Liberum

By Sudip Kar-Gupta

LONDON, Oct 16 (Reuters) - Britain's top share index rose onFriday, lifted by drugmaker Shire, whose shares climbedon speculation it could be lining up a bid for a U.S. rival.

The blue-chip FTSE 100 index ended up 0.6 percent at6,378.04 points.

Shire rose 3.2 percent, which traders attributed tospeculation it was preparing a bid for U.S. peer Radius Health,seen as a potentially good deal for the British group. Shiredeclined to comment on the situation.

Traders added that expectations of new stimulus measuresfrom China, the world's second-biggest economy, were givingequity markets a further lift.

Signs of a slowdown in China knocked back world stockmarkets in the third quarter, with the FTSE still down 4 percentsince the start of 2015, and down around 10 percent from anApril record high of 7,122.74 points.

"With half an eye on the possibility of more central bankstimulus, stocks have edged out a positive finish to the week,"said CMC Markets analyst Jasper Lawler.

Burberry was among the worst performing stocks onthe FTSE, falling 1.9 percent to extend the previous session'sslide, as a profit warning late on Thursday from Hugo Boss hit luxury goods companies.

Hugo Boss cut its 2015 sales and profit outlook, while pricetarget cuts from brokers on Burberry's shares on Friday addedfurther pressure to the British company, whose shares hadalready slumped 8.3 percent on Thursday on weak sales growth.

GKN and other engineering stocks also fell afterbrokerage Liberum cut estimates on the sector.

(Additional reporting by Kit Rees; Editing by Toby Chopra andMark Potter)

Related Shares

More News
Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.